Delisting risk
Immuron (ADR) (IMRN)
Oral bovine-colostrum products for digestive health and travelers’ diarrhea.
$1.18
Pre-market0.00 (0.00%)
At close$1.18(+10.28%)
In millions of USD, except per-share figures · converted from AUD at the latest rate
| In millions | Q4 FY22Jun 2022 | Q2 FY23Dec 2022 | Q4 FY23Jun 2023 | Q2 FY24Dec 2023 | Q3 FY24Mar 2024 | Q4 FY24Jun 2024 | Q1 FY25Sep 2024 | Q2 FY25Dec 2024 | Q3 FY25Mar 2025 | Q4 FY25Jun 2025 | Q2 FY26Dec 2025 | Q4 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 2 | 1 | 2 | 1 | 3 | 1 | 2 | 3 | 3 |
| Cost of revenue | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 1 | 1 | 1 |
| Gross profit | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 2 | 2 |
| 1 | 1 | 1 | 3 | 2 | 4 | 2 | 4 | 2 | 4 | 3 | 3 | |
| Research & development | 0 | 1 | 0 | 2 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 0 |
| 1 | 1 | 1 | 2 | 1 | 3 | 1 | 3 | 1 | 3 | 3 | 3 | |
| Selling & marketing | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 0 |
| General & administrative | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 1 | 2 | 0 | 0 |
| Other expenses | −1 | −1 | 0 | −1 | 0 | −1 | 0 | 0 | 0 | −1 | 0 | 1 |
| Operating income | −1 | −1 | −1 | −1 | −1 | −3 | −1 | −2 | −1 | −2 | −2 | −2 |
| 0 | 0 | 0 | 0 | 0 | −1 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Interest income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other non-operating income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income before tax | −1 | −1 | −1 | −1 | −2 | −3 | −1 | −2 | −1 | −2 | −2 | −2 |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | −1 | −1 | −1 | −1 | −2 | −3 | −1 | −2 | −1 | −2 | −1 | −1 |
| Net income | −1 | −1 | −1 | −1 | −2 | −3 | −1 | −2 | −1 | −2 | −1 | −1 |
| EPS, basic | −$0.13 | −$0.12 | −$0.11 | −$0.26 | −$0.31 | −$0.62 | −$0.16 | −$0.31 | −$0.17 | −$0.34 | −$0.19 | −$0.17 |
| EPS, diluted | −$0.13 | −$0.12 | −$0.11 | −$0.26 | −$0.31 | −$0.62 | −$0.16 | −$0.31 | −$0.17 | −$0.34 | −$0.19 | −$0.17 |
| Weighted average shares, basic | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 7 | 8 |
| Weighted average shares, diluted | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 7 | 8 |
| EBITDA | −1 | −1 | −1 | −1 | −1 | −2 | −1 | −2 | −1 | −2 | −2 | −2 |
| Depreciation & amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | −1 | −1 | −1 | −1 | −1 | −2 | −1 | −2 | −1 | −2 | −2 | −2 |